Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FVRR Fiverr International	$29.36 +2.5%	$30.16	$20.78 ▼ $36.11	$1.03B	1.58	677,017 shs	992,507 shs
GM General Motors	$49.25 -0.9%	$48.15	$38.96 ▼ $61.24	$47.76B	1.34	12.70 million shs	9.63 million shs
LAC Lithium Americas	$2.68 -3.2%	$2.81	$2.02 ▼ $5.20	$606.37M	0.68	5.43 million shs	3.33 million shs
RCKT Rocket Pharmaceuticals	$2.45 -3.2%	$4.85	$2.19 ▼ $26.98	$270.17M	0.69	2.16 million shs	3.11 million shs

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FVRR Fiverr International	+1.50%	+0.88%	-9.41%	+23.00%	+25.31%
GM General Motors	-0.89%	+1.42%	-0.67%	+4.40%	+6.01%
LAC Lithium Americas	-3.77%	+4.28%	0.00%	-3.07%	0.00%
RCKT Rocket Pharmaceuticals	-3.16%	-6.84%	-1.21%	-57.83%	-88.62%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FVRR Fiverr International	3.0795 of 5 stars	3.2	3.0	0.0	0.0	1.9	1.7	1.9
GM General Motors	4.0187 of 5 stars	2.1	4.0	2.5	0.0	2.1	1.7	2.5
LAC Lithium Americas	2.3898 of 5 stars	3.1	3.0	0.0	0.0	2.4	1.7	0.6
RCKT Rocket Pharmaceuticals	4.9085 of 5 stars	4.2	2.0	0.0	4.7	2.8	5.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FVRR Fiverr International	2.45	Hold	$36.00	22.62% Upside
GM General Motors	2.27	Hold	$53.35	8.33% Upside
LAC Lithium Americas	2.22	Hold	$3.88	44.59% Upside
RCKT Rocket Pharmaceuticals	2.41	Hold	$18.60	659.18% Upside

Current Analyst Ratings Breakdown

Latest RCKT, LAC, GM, and FVRR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/17/2025	RCKT Rocket Pharmaceuticals	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $5.00
6/3/2025	RCKT Rocket Pharmaceuticals	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$34.00 ➝ $11.00
5/30/2025	RCKT Rocket Pharmaceuticals	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ In-Line	$5.00
5/28/2025	RCKT Rocket Pharmaceuticals	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/28/2025	RCKT Rocket Pharmaceuticals	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral
5/28/2025	RCKT Rocket Pharmaceuticals	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$32.00 ➝ $9.00
5/28/2025	RCKT Rocket Pharmaceuticals	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$30.00 ➝ $8.00
5/28/2025	RCKT Rocket Pharmaceuticals	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Outperform ➝ Sector Outperform	$51.00 ➝ $19.00
5/28/2025	RCKT Rocket Pharmaceuticals	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell
5/28/2025	RCKT Rocket Pharmaceuticals	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform	$37.00 ➝ $8.00
5/23/2025	FVRR Fiverr International	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$39.00 ➝ $40.00

(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FVRR Fiverr International	$391.48M	2.69	$1.29 per share	22.83	$10.12 per share	2.90
GM General Motors	$187.44B	0.25	$23.12 per share	2.13	$65.92 per share	0.75
LAC Lithium Americas	N/A	N/A	N/A	N/A	$2.91 per share	N/A
RCKT Rocket Pharmaceuticals	N/A	N/A	N/A	N/A	$5.08 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FVRR Fiverr International	$18.25M	$0.47	62.47	23.49	N/A	4.51%	10.28%	3.39%	7/30/2025 (Estimated)
GM General Motors	$6.01B	$6.94	7.10	4.17	1.34	3.08%	14.30%	3.51%	7/22/2025 (Estimated)
LAC Lithium Americas	-$42.53M	-$0.16	N/A	N/A	N/A	N/A	-6.91%	-5.18%	8/12/2025 (Estimated)
RCKT Rocket Pharmaceuticals	-$258.75M	-$2.63	N/A	N/A	N/A	N/A	-64.92%	-56.13%	8/4/2025 (Estimated)

Latest RCKT, LAC, GM, and FVRR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/22/2025	Q2 2025	GM General Motors	$2.52	N/A	N/A	N/A	$45.87 billion	N/A
5/15/2025	Q1 2025	LAC Lithium Americas	-$0.04	-$0.05	-$0.01	-$0.05	N/A	N/A
5/13/2025	Q1 2025	RCKT Rocket Pharmaceuticals	-$0.58	-$0.56	+$0.02	N/A	N/A	N/A
5/5/2025	Q1 2025	RCKT Rocket Pharmaceuticals	-$0.59	-$0.56	+$0.03	-$0.56	$0.80 million	N/A
4/29/2025	Q1 2025	GM General Motors	$2.63	$2.78	+$0.15	$3.35	$42.64 billion	$44.02 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FVRR Fiverr International	N/A	N/A	N/A	N/A	N/A
GM General Motors	$0.60	1.22%	N/A	8.65%	3 Years
LAC Lithium Americas	N/A	N/A	N/A	N/A	N/A
RCKT Rocket Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Latest RCKT, LAC, GM, and FVRR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/29/2025	GM General Motors	quarterly	$0.15	1.27%	6/6/2025	6/6/2025	6/19/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FVRR Fiverr International	0.06	1.20	1.20
GM General Motors	1.46	1.21	1.04
LAC Lithium Americas	0.02	10.35	10.35
RCKT Rocket Pharmaceuticals	0.05	9.19	9.19

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FVRR Fiverr International	59.00%
GM General Motors	92.67%
LAC Lithium Americas	N/A
RCKT Rocket Pharmaceuticals	98.39%

Insider Ownership

Company	Insider Ownership
FVRR Fiverr International	15.90%
GM General Motors	0.54%
LAC Lithium Americas	1.11%
RCKT Rocket Pharmaceuticals	24.76%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FVRR Fiverr International	790	35.84 million	30.15 million	Optionable
GM General Motors	162,000	961.43 million	956.24 million	Optionable
LAC Lithium Americas	749	218.90 million	216.48 million	Not Optionable
RCKT Rocket Pharmaceuticals	240	106.79 million	80.35 million	Optionable

RCKT, LAC, GM, and FVRR Headlines

Recent News About These Companies

Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial – Hagens Berman

June 30 at 1:06 PM | globenewswire.com

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Rocket Pharmaceuticals, Inc. Investors of Upcoming Deadline

June 30 at 12:30 PM | globenewswire.com

The Gross Law Firm Reminds Rocket Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT

June 30 at 9:00 AM | prnewswire.com

Rocket Classic purse: How much can PGA Tour golfers make?

June 30 at 2:46 AM | indystar.comI

The Rocket Classic will have a new spot on the PGA Tour schedule in 2026

June 30 at 2:46 AM | msn.com

Rocket Classic 2025 leaderboard: Final results and scores from Detroit Golf Club

June 30 at 2:46 AM | msn.com

Aldrich Potgieter wins Rocket Classic after outlasting Max Greyserman, Chris Kirk

June 29 at 8:46 PM | msn.com

Rocket Classic notes: Is DGC about to become a par 70 for the PGA Tour?

June 29 at 8:46 PM | detroitnews.comD

2025 Rocket Classic live updates: Max Greyserman, Aldrich Potgieter on fifth playoff hole

June 29 at 8:46 PM | msn.com

Aldrich Potgieter wins Rocket Classic on 5th playoff hole, outlasting Max Greyserman and Chris Kirk

June 29 at 8:46 PM | msn.com

Aldrich Potgieter, 20, survives 'tough day,' emerges as Rocket champ in five-hole playoff

June 29 at 8:46 PM | detroitnews.comD

Rocket Classic 2025: Aldrich Potgieter survives wild three-man playoff to win in Detroit

June 29 at 8:46 PM | msn.com

Sovran Advisors LLC Purchases 172,324 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)

June 29 at 6:41 AM | marketbeat.com

Rocket Lab launches second Electron within 48 hours

June 28 at 2:28 PM | spacenews.comS

Rocket Lab launches 'Symphony of the Stars' mission

June 28 at 2:28 PM | msn.com

2025 Rocket Classic TV schedule, coverage, channel, golf live stream, where to watch PGA Tour event

June 28 at 2:28 PM | cbssports.com

What is the cut line at Rocket Classic? Who made and missed the cut?

June 28 at 2:28 PM | msn.com

Rocket Classic 2025: Third round live leaderboard updates, tee times, how to watch

June 28 at 2:28 PM | jsonline.comJ

2025 Rocket Classic leaderboard live updates: Golf scores, coverage in Round 3 with Collin Morikawa contending

June 28 at 2:28 PM | cbssports.com

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT

June 28 at 10:00 AM | globenewswire.com

RCKT Investors Have the Opportunity to Lead the Rocket Pharmaceuticals Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

June 28 at 8:30 AM | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

New Catalysts to Drive NVIDIA’s Stock Price Even Higher
By Thomas Hughes | June 16, 2025
View New Catalysts to Drive NVIDIA’s Stock Price Even Higher
Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
By Gabriel Osorio-Mazilli | June 23, 2025
View Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Higher Gulf Oil Output Puts These Energy Names in Play
By Gabriel Osorio-Mazilli | June 13, 2025
View Higher Gulf Oil Output Puts These Energy Names in Play
Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
By Ryan Hasson | June 3, 2025
View Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
FedEx Stock Is at Its Bottom—And It May Be Time to Buy
By Thomas Hughes | June 26, 2025
View FedEx Stock Is at Its Bottom—And It May Be Time to Buy

RCKT, LAC, GM, and FVRR Company Descriptions

Fiverr International NYSE:FVRR

$29.36 +0.72 (+2.51%)

Closing price 06/30/2025 03:58 PM Eastern

Extended Trading

$29.28 -0.08 (-0.27%)

As of 08:23 AM Eastern

Fiverr International Ltd. operates an online marketplace worldwide. Its platform enables sellers to sell their services and buyers to buy them. The company's platform includes various categories in ten verticals, including graphic and design, digital marketing, writing and translation, video and animation, music and audio, programming and tech, business, data, lifestyle, and photography. It also offers value-added products, including subscription-based content marketing, back-office, learning and development offerings, creative talent, and freelancer management platforms. In addition, the company provides a suite of professional solutions that enable businesses to engage with freelancers; Fiverr Pro, a marketplace; Fiverr Certified, a storefront to access certified experts for partner vendors; Fiverr Enterprise, a gateway to source and manage on-demand and long-term freelancers. Further, it offers various value-added products, including Promoted Gigs which allows sellers to advertise their services on the platform; and Seller Plus, a subscription program that equips sellers with advanced tools. The company's buyers include businesses of various sizes, as well as sellers comprise a group of freelancers and agencies. Fiverr International Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

General Motors NYSE:GM

$49.25 -0.43 (-0.87%)

Closing price 06/30/2025 03:58 PM Eastern

Extended Trading

$49.10 -0.15 (-0.30%)

As of 08:52 AM Eastern

General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.

Lithium Americas NYSE:LAC

$2.68 -0.09 (-3.25%)

Closing price 06/30/2025 03:58 PM Eastern

Extended Trading

$2.68 +0.00 (+0.04%)

As of 08:58 AM Eastern

Lithium Americas Corp. engages in the exploration and development of lithium properties in the United States and Canada. It holds a 100% interest in the Thacker Pass project located in northern Nevada, as well as investments in exploration properties in the United States and Canada. Lithium Americas Corp. was incorporated in 2023 and is headquartered in Vancouver, Canada.

Rocket Pharmaceuticals NASDAQ:RCKT

$2.45 -0.08 (-3.16%)

Closing price 06/30/2025 04:00 PM Eastern

Extended Trading

$2.44 -0.01 (-0.20%)

As of 08:58 AM Eastern

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure; Plakophilin-2 Arrhythmogenic Cardiomyopathy, an inheritable cardiac disorder; and BAG3 Dilated Cardiomyopathy. It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time